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The PTPIP51 TPR-Domain: A Novel Lipid
Transfer Domain?
Francesca Giordano 1,2 and Chrisostomos Prodromou 3
During the last decade, mitochondria-associated ER mem-
branes (MAMs) have emerged as critical signaling, meta-
bolic and trafficking hubs involved in the regulation of
multiple cellular processes including autophagy, inflamma-
tion, signaling and apoptosis (Csordas et al., 2018; Phillips
& Voeltz, 2016; Rowland & Voeltz, 2012). MAMs are
zones of close membrane proximity where the ER and mito-
chondria membranes are tethered by multiple linker proteins,
allowing direct exchange of key metabolites and ions, such as
lipids and Ca2+, between these two organelles that are not
connected by the classical vesicle-transport routes. While
the mechanism and proteins involved in Ca2+ transport at
the MAMs are well characterized, our knowledge on how
lipids are exchanged between these two organelles is still
rudimentary, especially in metazoa, as the lipid transfer pro-
teins (LTPs) have just started to be identified. Writing in
EMBO Reports, Yeo and colleagues (Yeo et al., 2021)
reveal a new role of the mitochondrial protein PTPIP51
(also known as Regulator of Microtubule Dynamics,
RMD3) in lipid transfer at MAMs. PTPIP51 has been pre-
viously shown to be a tether that bridges ER and mitochon-
dria membranes via interaction with the ER protein VAPB,
thus facilitating Ca2+ transport to mitochondria (Stoica
et al., 2014). However, the exact biochemical function of
PTPIP51 beyond ER-mitochondria tethering had so far
been unclear.
PTPIP51 possesses tandem FFAT motifs involved in the
binding to VAP (Di Mattia et al., 2020; Mikitova &
Levine, 2012), a coiled coil (CC) domain and a large
C-terminal globular domain, the tetratricopeptide repeat
(TPR) whose role in PTPIP51 function remains enigmatic.
With over 100 TPR structures deposited in the protein data
bank, the TPR domain has established itself as a major
protein-protein interaction module (Blatch & Lassle, 1999).
A diverse array of protein ligands has been seen to bind
within the TPR cleft. These do not share any common
sequence or secondary structure. Moreover, the diversity of
the ligand and the amino-acid residues that line the binding
cleft of the TPR domain produce highly specific TPR
binding domains. Yeo and colleagues reveal a novel role
for the TPR of PTPIP51 in binding and transferring phospho-
lipids that is unusual if compared to the established protein-
protein interaction mode of other TPR domains. On this line,
Yeo and colleagues show that interaction of PTPIP51 with
VAPB is not mediated by the TPR domain but by the
tandem FFAT-like motif. Then, they provide evidence that
suggests that the PTPIP51 TPR-domain is involved in phos-
pholipid binding and transfer at MAMs. The authors present
the X-ray structure of the TPR domain of PTPIP51 and bio-
chemical evidence in vitro and in situ for a lipid binding and
transfer function. They propose that the PTPIP51−VAPB
complex might be the counterpart of the yeast ER–mitochon-
dria encounter structure (ERMES) complex, responsible for
phospholipid transportation at MAMs (AhYoung et al.,
2015; Kornmann et al., 2009; Tatsuta et al., 2014).
Although other LTPs are also present at contact sites
between ER and mitochondria (i.e. ORP5/8, PDZD8,
VPS13A), the unexpected finding that the PTPIP51 TPR
domain could be involved in lipid trafficking at the same
interface is very intriguing and naturally deserves closer
scrutiny.
However, before we discuss this, it would be useful to
draw some information from structures that are known to
be lipid trafficking proteins (LTPs) at regions of close mem-
brane apposition, including MAMs. There are several major
families of LTPs that localize at membrane contact sites, each
containing a core lipid-binding/transfer domain (Giordano,
2018), that include oxysterol-binding protein
(OSBP)-related proteins (ORD), START, START/VASt,
PITPs, PRELI-like, and SMP domains, that collectively act
as tethers, lipid sensors, or transporters at multiple contact
sites (Giordano, 2018). Looking at examples of such
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structures (Osh6, the yeast orthologous of ORP5/8, PDB
4PH7; human phosphatidylcholine transfer protein, PDB
1LN1; Ysp2p, PDB 6CAY and the SMP domain of
Mmm1, PDB 5YK6) we see that these structures suggest a
common theme by which MAM associated phospholipid
transfer proteins bind their ligands within solvent inaccess-
ible sites. Furthermore, LTPs such as PITP-alpha and Beta
(PDB, 1KCM and 2A1L, respectively) also bury their
bound ligand. However, an exception to this rule is seen
for mitochondrial PRELID1 (PDB, 6I3Y), where the phos-
phatidylserine (PS) is bound in a deep cleft, but is solvent
exposed. This latter example indicates that a TPR domain,
with a solvent exposed channel, might be implicated in
binding phospholipid. Furthermore, it is not inconceivable
that such a binding event could occur as this has been demon-
strated for MHC and CD1 proteins (Grant et al., 1999;
Rossjohn et al., 2015; Salomonsen et al., 2005)
The structural data shown by Yeo and colleagues reveal
that the TPR in PTPIP51 consists in 12 alpha-helices
forming several antiparallel TPR units, two of them (TPR2
and TPR3) generating a deep channel-shaped cavity
covered on one side by the alpha-helix 8 (α8) as a plug.
Another unusual feature of this TPR domain is helix 12,
which lies across the top of the TPR cleft and restricts it some-
what. The significance of helix 8 and 12 remains unknown.
Structural evidence for a lipid-like molecule being bound to
the TPR cleft of PTPIP51was aweak, tube-shaped, serpentine
electron density observed in the electron density map of the
structure. The crystals were grown in the presence of
Sokalan 42, a modified polycarboxylate, which might
account for this electron density, but in doing so was mimick-
ing the binding of a phospholipid. Alternatively, a lipid from
the expression host could have been weakly bound. However,
attempts to refine this or determine the molecule responsible
for this electron density failed. Electron density for a bound
head group, assuming such a lipid was bound, was unfortu-
nately lacking, indicating that a head group was either
absent or disordered. As with the Mmm1 structure, the head
groups of its bound phospholipid might be exposed to
solvent, which may indicate a low specificity for phospholi-
pid, where the head group could be quite variable.
In support for the PTPIP51 TPR domain being involved
in phospholipid binding, a series of biochemical assays
were conducted. First, the authors performed PIP-strip
lipid-binding assays, using purified recombinant proteins,
PTPIP51_ΔTM, PTPIP51_TPR, and PTPIP51_ΔTPR
(residues 36–235) proteins. They found that the PTPIP51
TPR domain has a binding preference for PtdIns(4)P,
PtdIns(5)P, and phosphatidic acid (PA), over cardiolipin
(CL), di-PtdIns, phosphatidylethanolamine (PE) and phos-
phatidylcoline (PC). The construct lacking the TM domain
showed a wider spectrum of affinity, binding a variety of
PtIns, PA, PS and CL. Only PtdIns(5)P interacted with
all three constructs of PTPIP51. Although PIP-strip lipid
binding assays allow us to address the ability of a
protein surface to interact with lipids they do not allow
us to determine the ability of the TPR domain to extract
and bind lipids within its cleft. Thus, the authors also con-
ducted in vitro liposomes-based lipid precipitation assays
using PTPIP51_ΔTM and PTPIP51_TPR, confirming the
ability of PTPIP51_ΔTM to bind PA, CL and PtdIns(4)
P, but not PS, PC and PE. The interaction between
PTPIP51_ΔTM and PA was further investigated, and con-
firmed, by a sucrose gradient liposome flotation assay in
vitro. Collectively, these experiments showed that
PTPIP51 has a broad lipid binding affinity suggesting
that some variability in the head group interaction with
the TPR domain is possible.
Finally, the authors evaluate the PA transfer activity of
PTPIP51 using a FRET-based in vitro PA transfer assay.
The assay showed a clear dose-dependent PA transfer by
PTPIP51, which was higher with the PTPIP51_ΔTM con-
struct than with PTPIP51_TPR. However, a negative
control, such as a TPR mutant, was not used in these experi-
ments. It was also noted that the kinetics of PA transfer was
rather slow to be physiological, but that this was probably
due to fundamental limitations of the in vitro assay.
Finally, an alternative bead pulldown-based fluorescence
lipid transfer assay was performed, in vitro, which showed
a PA and monolysocardiolipin transfer activity of PTPIP51.
The authors finally conclude that PTPIP51 can bind and
transfer lipids such as PA in vitro.
PA, that is synthesized in the ER, needs to be shuttled
from the ER to the mitochondria at contact sites as it is the
precursor of CL, a key lipid of mitochondria required to
maintain their structural and functional integrity. By using
a spectrophotometric assay the authors found that PTPIP51
knockdown in HeLa cells decreases levels of CL. The
decrease was weak but statistically significant. Although
further lipidomic analysis did not measure a significant
decrease in CL upon PTPIP51 downregulation, an increase
in CL levels was found upon re-expression of PTPIP51,
possibly as a result of both its lipid transfer and tethering
activity (overexpression of PTPIP51 strongly increases
ER-mitochondria contact sites). Yeo and colleagues
conclude that PTPIP51 mediates PA transfer at ER-mito-
chondria junctions in situ. Unexpectedly, a mutant deleted
in the FFAT motifs was also able to rescue CL decrease,
indicating that the function of PTPIP51 on mitochondrial
CL does not require its interaction with VAPB. This
finding highlights a peculiarity of PTPIP51 versus other
FFAT-proteins, that instead seem to require
FFAT-mediated interaction with VAP for their lipid transfer
function (for example, STARD3 requires FFAT-mediated
interaction with VAP for its sterol transfer function both in
vitro and in vivo (Di Mattia et al., 2020)). PTPIP51 has
been shown to also interact with ORP5/8 (Galmes et al.,
2016), which could bind PTPIP51 TPR domain and compen-
sate for the loss of interaction with VAPB. Further studies
would be needed to address this possibility and to analyse
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the effects of the TPR and FFAT mutants on ORP5/8 binding
and on the morphology of ER-mitochondria contact sites.
Overall, the experiments performed by Yeo and collea-
gues show that the exact lipid transfer activity of PTPIP51
appears to be construct dependant, which can be difficult to
rationalise. This raises specific questions and further
research, in our opinion, is required before this TPR
domain is categorised as lipid binding. A next step would
be to use a simple mutation in the cavity of the TPR
domain, close to the serpentine electron density, that would
sterically prevent lipid binding and confirm binding within
the TPR cleft. Crystallization of the TPR domain with phos-
pholipid would ultimately identify the exact interaction site
on the TPR domain. The TPR mutant could be also used
for rescue experiments in situ to confirm a direct role of
PTPIP51 in lipid transfer (Figure, left (I)) and to exclude pos-
sible indirect effects due to its tethering function or its inter-
action with other LTPs, such as ORP5/8 (Figure 1, right (II)).
To conclude, while the results are exciting in that a TPR
domain can interact with phospholipid, direct structural evi-
dence for this is still tantalisingly out of reach. Hence, the
authors lay a platform from which additional experimentation
is evident to strengthen the argument for the role of PTPIP51
TPR in non-vesicular lipid transfer in vitro and at
ER-mitochondria contact sites.
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